CEACAM3 and cancer: Furthermore, intravenous and subcutaneous administration of MEDI-565 had anticancer activity in severe combined immunodeficient mouse xenograft models of various human cancers [18]; growth inhibition of the cancers was contingent on both the presence of un-stimulated human T cells and the expression of CEA on the cancer cells [18].